Evaluation of a Medication Health Center to Promote Opioid Safety
Overview
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Kaiser Permanente
- Enrollment
- 14
- Locations
- 1
- Primary Endpoint
- Number of participants with a Medication Health Center visit
Overview
Brief Summary
This study will assess the impact of an opioid safety clinic intervention for patients prescribed chronic opioid therapy. Outcomes are visits to the clinic, naloxone dispensings, Prescription Drug Monitoring reviews, and Urine Drug Screens conducted
Detailed Description
Given ongoing concerns about the risk of opioid overdose among people taking chronic opioid therapy for pain, Kaiser Permanente Colorado (KPCO) sought to develop a standardized approach to promote opioid safety. Operational stakeholders adapted an existing Opioid Safety Clinic model, tailored it for KPCO's context, and implemented it in three geographically dispersed KPCO clinics with leadership support. The approach was a multidisciplinary "Medication Health Center" to assess patients, educate them about overdose risk, provide naloxone, and ensure adherence to standard monitoring. Operations and the research team then collaborated to assess the effectiveness of the program to inform decisions to scale the program to other regions.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Prevention
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Number of participants with a Medication Health Center visit
Time Frame: Outcomes are assessed in a two-month post-intervention period.
Medication Health Center (MHC) Visits will be assessed using data from the electronic medical record.
Secondary Outcomes
- Number of participants with a Urine Drug Screens completed(Outcomes are assessed in a two-month post-intervention period.)
- Number of participants with a Naloxone dispensing(Outcomes are assessed in a two-month post-intervention period.)
- Number of participants with a Prescription Drug Monitoring Program (PDMP) review(Outcomes are assessed in a two-month post-intervention period.)